Stockreport

Senate Begins Investigation Into Ozempic and Wegovy Prices [The New York Times]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF A Senate committee is investigating the prices that Novo Nordisk charges for its blockbuster medications, Ozempic and Wegovy, which are highly effective at treating diab [Read more]